ROBLOX CORP -CLASS A (RBLX) Stock Fundamental Analysis
NYSE:RBLX - New York Stock Exchange, Inc. - US7710491033 - Common Stock - Currency: USD
RBLX gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 72 industry peers in the Entertainment industry. The financial health of RBLX is average, but there are quite some concerns on its profitability. RBLX is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
RBLX had negative earnings in the past year.
RBLX had a positive operating cash flow in the past year.
RBLX had negative earnings in each of the past 5 years.
In the past 5 years RBLX always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of RBLX (-11.81%) is worse than 68.06% of its industry peers.
RBLX has a Return On Equity of -283.19%. This is amonst the worse of the industry: RBLX underperforms 80.56% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.81% | ||
| ROE | -283.19% | ||
| ROIC | N/A |
ROA(3y)-16.3%
ROA(5y)-14.68%
ROE(3y)-744.81%
ROE(5y)-518.53%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
RBLX's Gross Margin of 77.92% is amongst the best of the industry. RBLX outperforms 90.28% of its industry peers.
RBLX's Gross Margin has been stable in the last couple of years.
RBLX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 77.92% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.61%
GM growth 5Y0.48%
2. Health
2.1 Basic Checks
RBLX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, RBLX has more shares outstanding
RBLX has more shares outstanding than it did 5 years ago.
The debt/assets ratio for RBLX has been reduced compared to a year ago.
2.2 Solvency
RBLX has an Altman-Z score of 5.14. This indicates that RBLX is financially healthy and has little risk of bankruptcy at the moment.
RBLX has a Altman-Z score of 5.14. This is amongst the best in the industry. RBLX outperforms 83.33% of its industry peers.
The Debt to FCF ratio of RBLX is 1.15, which is an excellent value as it means it would take RBLX, only 1.15 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.15, RBLX belongs to the top of the industry, outperforming 81.94% of the companies in the same industry.
RBLX has a Debt/Equity ratio of 3.24. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of RBLX (3.24) is worse than 75.00% of its industry peers.
Although RBLX does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.24 | ||
| Debt/FCF | 1.15 | ||
| Altman-Z | 5.14 |
ROIC/WACCN/A
WACC8.93%
2.3 Liquidity
A Current Ratio of 1.02 indicates that RBLX should not have too much problems paying its short term obligations.
With a Current ratio value of 1.02, RBLX perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
RBLX has a Quick Ratio of 1.02. This is a normal value and indicates that RBLX is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of RBLX (1.02) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.02 | ||
| Quick Ratio | 1.02 |
3. Growth
3.1 Past
RBLX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.57%, which is quite impressive.
RBLX shows a strong growth in Revenue. In the last year, the Revenue has grown by 30.24%.
Measured over the past years, RBLX shows a very strong growth in Revenue. The Revenue has been growing by 47.93% on average per year.
EPS 1Y (TTM)29.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.58%
Revenue 1Y (TTM)30.24%
Revenue growth 3Y23.35%
Revenue growth 5Y47.93%
Sales Q2Q%30.63%
3.2 Future
Based on estimates for the next years, RBLX will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.03% on average per year.
Based on estimates for the next years, RBLX will show a quite strong growth in Revenue. The Revenue will grow by 16.55% on average per year.
EPS Next Y-2.09%
EPS Next 2Y7.56%
EPS Next 3Y12.03%
EPS Next 5YN/A
Revenue Next Year23.49%
Revenue Next 2Y21.83%
Revenue Next 3Y20.14%
Revenue Next 5Y16.55%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for RBLX. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RBLX. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
RBLX's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 78.98 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as RBLX's earnings are expected to grow with 12.03% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.56%
EPS Next 3Y12.03%
5. Dividend
5.1 Amount
RBLX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
102.09
-0.56 (-0.55%)
Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)
Earnings (Next)
Inst Owners78.64%
Inst Owner Change-0.51%
Ins Owners4.92%
Ins Owner Change0.37%
Market Cap69.25B
Analysts76.5
Price Target75.59 (-25.96%)
Short Float %2.8%
Short Ratio1.97
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.92%
Min EPS beat(2)21.55%
Max EPS beat(2)28.29%
EPS beat(4)4
Avg EPS beat(4)20.7%
Min EPS beat(4)13.59%
Max EPS beat(4)28.29%
EPS beat(8)7
Avg EPS beat(8)15.39%
EPS beat(12)8
Avg EPS beat(12)3.94%
EPS beat(16)9
Avg EPS beat(16)-16.1%
Revenue beat(2)1
Avg Revenue beat(2)0.4%
Min Revenue beat(2)-2.6%
Max Revenue beat(2)3.4%
Revenue beat(4)3
Avg Revenue beat(4)3.31%
Min Revenue beat(4)-2.6%
Max Revenue beat(4)8.2%
Revenue beat(8)4
Avg Revenue beat(8)1.35%
Revenue beat(12)4
Avg Revenue beat(12)-5.15%
Revenue beat(16)4
Avg Revenue beat(16)-10.27%
PT rev (1m)4.52%
PT rev (3m)11.07%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-12.31%
EPS NY rev (1m)0%
EPS NY rev (3m)3.39%
Revenue NQ rev (1m)0.33%
Revenue NQ rev (3m)1.94%
Revenue NY rev (1m)0.11%
Revenue NY rev (3m)1.9%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 18.05 | ||
| P/FCF | 78.98 | ||
| P/OCF | 67.41 | ||
| P/B | 222.88 | ||
| P/tB | 499.13 | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.31
EYN/A
EPS(NY)-1.2
Fwd EYN/A
FCF(TTM)1.29
FCFY1.27%
OCF(TTM)1.51
OCFY1.48%
SpS5.66
BVpS0.46
TBVpS0.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.81% | ||
| ROE | -283.19% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 77.92% | ||
| FCFM | 22.86% |
ROA(3y)-16.3%
ROA(5y)-14.68%
ROE(3y)-744.81%
ROE(5y)-518.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.61%
GM growth 5Y0.48%
F-Score6
Asset Turnover0.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.24 | ||
| Debt/FCF | 1.15 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 66.47% | ||
| Cap/Sales | 3.92% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.02 | ||
| Quick Ratio | 1.02 | ||
| Altman-Z | 5.14 |
F-Score6
WACC8.93%
ROIC/WACCN/A
Cap/Depr(3y)189.75%
Cap/Depr(5y)192.24%
Cap/Sales(3y)12.06%
Cap/Sales(5y)10.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.58%
EPS Next Y-2.09%
EPS Next 2Y7.56%
EPS Next 3Y12.03%
EPS Next 5YN/A
Revenue 1Y (TTM)30.24%
Revenue growth 3Y23.35%
Revenue growth 5Y47.93%
Sales Q2Q%30.63%
Revenue Next Year23.49%
Revenue Next 2Y21.83%
Revenue Next 3Y20.14%
Revenue Next 5Y16.55%
EBIT growth 1Y20.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year195.48%
EBIT Next 3Y54.41%
EBIT Next 5Y37.7%
FCF growth 1Y1181.11%
FCF growth 3Y4.75%
FCF growth 5Y113.37%
OCF growth 1Y165.65%
OCF growth 3Y7.65%
OCF growth 5Y52.65%